PedAM
Pediatric Disease Annotations & Medicines
| Disease | lung cancer |
| Phenotype | C0024623|gastric cancer |
| Sentences | 4 |
| PubMedID- 26468480 | In this study, 60 patients with gastric and lung cancers (33 cases with gastric cancer and 27 cases with lung cancer) were enrolled in 2 groups of 30 patients. |
| PubMedID- 25947890 | Kurishima and colleagues had reported that the incidence rate of synchronous gastric cancer in patients with lung cancer was 3.2% [29]. |
| PubMedID- 22996774 | Results: thirteen cases of lung cancer, eight with gastric cancer, and one with esophageal cancer, were retrospectively evaluated. |
| PubMedID- 26496252 | Bevacizumab is a recombinant, humanized murine monoclonal antibody against vascular endothelial growth factor a (vegf-a).9 bevacizumab has been shown effective when used alone or in combination with other chemotherapies in treating several malignancies, such as metastatic renal cell cancer,10 metastatic colorectal cancer,11 metastatic breast cancer,12 and metastatic nonsquamous nonsmall-cell lung cancer.13 in patients with advanced gastric cancer, several phase ii studies suggest that the addition of bevacizumab improves the efficacy of chemotherapy, such as oxaliplatin, docetaxel, cisplatin, and fluorouracil.14,15 although the initial results of the phase iii study avagast did not show beneficial effects of bevacizumab for patient survival as the first-line treatment for advanced gastric cancer,16 further analysis of the data suggest that certain subgroups may have benefited from the addition of bevacizumab to chemotherapy. |
Page: 1